|
FR2295746A1
(fr)
|
1974-12-23 |
1976-07-23 |
Francaise Coop Pharma |
Nouveaux derives du tryptophane a activite nerveuse centrale renforcee
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
IT1179866B
(it)
|
1984-12-12 |
1987-09-16 |
Rotta Research Lab |
Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
|
|
US4576750A
(en)
|
1985-04-22 |
1986-03-18 |
Merck & Co., Inc. |
Tryptophan derivative
|
|
US5157110A
(en)
|
1988-08-20 |
1992-10-20 |
The Government Of The United States Of America |
Synthetic, anti-complement protein
|
|
IL95942A0
(en)
|
1989-10-13 |
1991-07-18 |
Syntex Inc |
Collagen-containing ophthalmic formulation
|
|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
|
EP0512733A2
(en)
|
1991-05-03 |
1992-11-11 |
Washington University |
Modified complement system regulator
|
|
US5492135A
(en)
|
1992-09-09 |
1996-02-20 |
Devore; Dale P. |
Collagen modulators for use in photoablation excimer laser keratectomy
|
|
US5482135A
(en)
|
1993-06-29 |
1996-01-09 |
Deere & Company |
Combined hydraulic reservoir and vehicle axle
|
|
WO1995003009A1
(en)
|
1993-07-22 |
1995-02-02 |
Oculex Pharmaceuticals, Inc. |
Method of treatment of macular degeneration
|
|
WO1995003807A1
(en)
|
1993-07-27 |
1995-02-09 |
The University Of Sydney |
Treatment of age-related macular degeneration
|
|
US5470952A
(en)
|
1993-10-20 |
1995-11-28 |
Regeneron Pharmaceuticals, Inc. |
CNTF and IL-6 antagonists
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5776970A
(en)
|
1994-04-28 |
1998-07-07 |
Yeda Research And Development Co. Ltd. |
Tryptophan derivatives as protein tyrosine kinase blockers and their use in the treatment of neoplastic diseases
|
|
IL117645A
(en)
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
|
JPH08280800A
(ja)
|
1995-04-12 |
1996-10-29 |
Nissho Corp |
２液注射用プレフィルドシリンジ
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
|
US6346398B1
(en)
|
1995-10-26 |
2002-02-12 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
|
|
JP2000505068A
(ja)
|
1996-03-13 |
2000-04-25 |
トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア |
補体活性化を阻害する新規ペプチド類
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5843778A
(en)
|
1996-06-14 |
1998-12-01 |
The Johns Hopkins University School Of Medicine |
Use of chimeric vaccinia virus complement control proteins to inhibit complement
|
|
JPH1087700A
(ja)
|
1996-06-17 |
1998-04-07 |
Smithkline Beecham Corp |
Ｃ３ａ受容体およびＣ３ａを用いる治療およびスクリーニング方法
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US6051698A
(en)
|
1997-06-06 |
2000-04-18 |
Janjic; Nebojsa |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
|
CN1269013A
(zh)
|
1997-04-11 |
2000-10-04 |
高级药品有限公司 |
呈递多个活性部分的分子
|
|
WO1998047002A2
(en)
|
1997-04-11 |
1998-10-22 |
Advanced Medicine, Inc. |
Polyvalent presenter combinatorial libraries and their uses
|
|
AUPO755097A0
(en)
|
1997-06-25 |
1997-07-17 |
University Of Queensland, The |
Receptor agonist and antagonist
|
|
US6169057B1
(en)
|
1997-09-04 |
2001-01-02 |
The Regents Of The University Of California |
Use of tryptophan and analogs as plant growth regulators
|
|
AU4648197A
(en)
|
1997-09-17 |
1999-04-05 |
Burnham Institute, The |
Peptides and peptidomimetics for inhibiting complement activation
|
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
JPH11197234A
(ja)
|
1998-01-09 |
1999-07-27 |
Koken Co Ltd |
眼科用コラーゲンゲル成形物
|
|
US7112327B2
(en)
|
1998-02-20 |
2006-09-26 |
Tanox, Inc. |
Inhibition of complement activation
|
|
WO1999044625A1
(en)
|
1998-03-03 |
1999-09-10 |
John Hopkins University |
Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation
|
|
AU3485999A
(en)
|
1998-04-10 |
1999-11-01 |
Mayo Foundation For Medical Education And Research |
Neo-tryptophan
|
|
US6197934B1
(en)
|
1998-05-22 |
2001-03-06 |
Collagenesis, Inc. |
Compound delivery using rapidly dissolving collagen film
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US7084106B1
(en)
|
1999-01-19 |
2006-08-01 |
University Of Louisville Research Foundation, Inc. |
Application of a viral complement inhibitory protein in the treatment and diagnosis of Alzheimer's Disease
|
|
US6645177B1
(en)
|
1999-02-09 |
2003-11-11 |
Alaris Medical Systems, Inc. |
Directly engaged syringe driver system
|
|
EP1154734B1
(en)
|
1999-02-12 |
2014-10-01 |
ProChon Biotech Ltd. |
Injectable collagen-based system for delivery of cells
|
|
US20020102581A1
(en)
|
1999-02-19 |
2002-08-01 |
Hageman Gregory S. |
Diagnostics and therapeutics for ocular disorders
|
|
US7108982B1
(en)
|
1999-02-19 |
2006-09-19 |
University Of Iowa Research Foundation |
Diagnostics and the therapeutics for macular degeneration
|
|
GB9910985D0
(en)
|
1999-05-12 |
1999-07-14 |
Smiths Industries Plc |
Syringe pumps
|
|
WO2000071147A1
(en)
|
1999-05-25 |
2000-11-30 |
King Faisal Specialist Hospital And Research Centre |
Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
|
|
IT1307266B1
(it)
|
1999-08-13 |
2001-10-30 |
Cane Srl |
Apparecchio per infusione di farmaci.
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
GB9930659D0
(en)
|
1999-12-24 |
2000-02-16 |
Bio Discovery Ltd |
Inhibitors of complement activation
|
|
US20050032733A1
(en)
|
2001-05-18 |
2005-02-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
|
|
US20050020525A1
(en)
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US7011952B2
(en)
|
2000-02-22 |
2006-03-14 |
University Of Iowa Research Foundation |
Diagnostics and therapeutics for macular degeneration-related disorders
|
|
EP1309726B2
(en)
|
2000-03-30 |
2018-10-03 |
Whitehead Institute For Biomedical Research |
Rna sequence-specific mediators of rna interference
|
|
EP2026073B1
(en)
|
2000-04-29 |
2016-03-30 |
University Of Iowa Research Foundation |
Diagnostics and therapeutics for macular degeneration-related disorders
|
|
US6692759B1
(en)
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
WO2002011793A1
(fr)
|
2000-08-08 |
2002-02-14 |
Medical Information Services, Inc. |
Seringue pour preparation de necessaire d'injection, valve coulissante intermediaire pour seringues et preparation de necessaire d'injection
|
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
|
AU2001296594A1
(en)
|
2000-10-10 |
2002-04-22 |
Tanox, Inc. |
Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
|
|
ES2314781T3
(es)
|
2000-11-09 |
2009-03-16 |
Insulet Corporation |
Medios de suministro transcutaneo.
|
|
RU2322500C2
(ru)
|
2000-12-01 |
2008-04-20 |
Макс-Планк-Гезелльшафт Цур Фердерунг Дер Виссеншафтен Е.Ф. |
Малые молекулы рнк, опосредующие интерференцию рнк
|
|
EP1345629A2
(en)
|
2000-12-29 |
2003-09-24 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having sustained release properties
|
|
EP1372602B1
(en)
|
2001-01-09 |
2007-04-18 |
Microchips, Inc. |
Flexible microchip devices for ophthalmic and other applications
|
|
US7611711B2
(en)
|
2001-01-17 |
2009-11-03 |
Vegenics Limited |
VEGFR-3 inhibitor materials and methods
|
|
US20050054596A1
(en)
|
2001-11-30 |
2005-03-10 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
US20030171320A1
(en)
|
2001-11-09 |
2003-09-11 |
Guyer David R. |
Methods for treating ocular neovascular diseases
|
|
AU2002365603A1
(en)
|
2001-12-04 |
2003-06-17 |
Nanospectra Biosciences, Inc. |
Treatment of angiogenesis disorders using targeted nanoparticles
|
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
AUPS160602A0
(en)
|
2002-04-08 |
2002-05-16 |
University Of Queensland, The |
Therapeutic method
|
|
US7150724B2
(en)
|
2002-06-05 |
2006-12-19 |
Cardinal Health 303, Inc. |
Syringe plunger driver system
|
|
US7018361B2
(en)
|
2002-06-14 |
2006-03-28 |
Baxter International Inc. |
Infusion pump
|
|
WO2003105780A2
(en)
|
2002-06-18 |
2003-12-24 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
ITMI20021527A1
(it)
|
2002-07-11 |
2004-01-12 |
Consiglio Nazionale Ricerche |
Anticorpi anti componente c5 del complemento e loro uso
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
JP3976635B2
(ja)
|
2002-08-05 |
2007-09-19 |
久光製薬株式会社 |
キット製剤用注射器、注射器型キット製剤用中間摺動弁、及び、注射器型キット製剤、並びにｘ線造影剤キット製剤
|
|
EP2311480B1
(en)
|
2002-09-20 |
2013-06-26 |
The Trustees of The University of Pennsylvania |
Compstatin analogs with improved activity
|
|
WO2004028635A1
(en)
|
2002-09-27 |
2004-04-08 |
Novartis Ag |
Ocular gene therapy
|
|
EP1553993B1
(en)
|
2002-10-21 |
2016-03-30 |
Allvivo, Inc. |
Surface coating comprising bioactive compound
|
|
US7595430B2
(en)
|
2002-10-30 |
2009-09-29 |
University Of Kentucky Research Foundation |
Methods and animal model for analyzing age-related macular degeneration
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
WO2004075837A2
(en)
|
2003-02-21 |
2004-09-10 |
Tanox, Inc. |
Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
|
|
JP2006518750A
(ja)
|
2003-02-21 |
2006-08-17 |
リクスホスピタレット−ラジウムホスピタレット・ホーエフ |
胎便吸引症候群の治療のための方法および組成物
|
|
US20050255144A1
(en)
|
2003-04-09 |
2005-11-17 |
Directcontact Llc |
Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
|
|
WO2005023296A1
(en)
|
2003-09-05 |
2005-03-17 |
University Of Louisville Research Foundation, Inc. |
Treatment of rheumatic diseases
|
|
WO2005023866A2
(en)
|
2003-09-10 |
2005-03-17 |
Baxter International Inc. |
Peptides that inhibit complement activation
|
|
DK1713503T3
(da)
|
2004-02-10 |
2013-11-04 |
Univ Colorado Regents |
Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde
|
|
PL3385384T3
(pl)
|
2004-02-12 |
2021-03-08 |
Archemix Llc |
Aptamerowe środki terapeutyczne użyteczne w leczeniu zaburzeń powiązanych z dopełniaczem
|
|
WO2005110374A1
(en)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
CN1950095A
(zh)
|
2004-05-10 |
2007-04-18 |
诺瓦西股份有限公司 |
用活性的维生素d化合物预防动脉再狭窄
|
|
US8840893B2
(en)
|
2004-06-10 |
2014-09-23 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
|
EP1768692B8
(en)
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US7947267B2
(en)
|
2004-10-08 |
2011-05-24 |
Potentia Pharmaceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
US8043609B2
(en)
|
2004-10-08 |
2011-10-25 |
Potentia Pharmaceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
WO2006062716A2
(en)
|
2004-11-18 |
2006-06-15 |
Yale University |
Methods and compositions for treating ocular disorders
|
|
EP2357257B1
(en)
|
2005-02-14 |
2019-07-31 |
University of Iowa Research Foundation |
Methods and reagents for treatment and diagnosis of age-related macular degeneration
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US20090117171A1
(en)
|
2005-03-11 |
2009-05-07 |
Cedric Francois |
Compositions and methods for treatment of macular degeneration and related conditions
|
|
US20080097291A1
(en)
|
2006-08-23 |
2008-04-24 |
Hanson Ian B |
Infusion pumps and methods and delivery devices and methods with same
|
|
EP2377884A1
(en)
*
|
2005-05-10 |
2011-10-19 |
Neoloch Aps |
Neuritogenic peptides
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
JP5345849B2
(ja)
|
2005-10-08 |
2013-11-20 |
ポテンシア ファーマシューティカルズ， インコーポレイテッド |
眼の障害のためのコンプスタチンおよびそのアナログ
|
|
US20070134244A1
(en)
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
|
ES2551202T5
(es)
|
2005-11-04 |
2018-11-30 |
Genentech, Inc. |
Uso de inhibidores de la vía del complemento para tratar enfermedades oculares
|
|
EP1960422B1
(en)
|
2005-11-28 |
2012-05-30 |
The Trustees of The University of Pennsylvania |
Potent compstatin analogs
|
|
US20070149616A1
(en)
|
2005-12-22 |
2007-06-28 |
Alcon Manufacturing, Ltd. |
C3-Convertase Inhibitors for the Prevention and Treatment of Age-Related Macular Degeneration in Patients With At Risk Variants Of Complement Factor H
|
|
ATE409280T1
(de)
|
2005-12-28 |
2008-10-15 |
Sensile Pat Ag |
Mikropumpe
|
|
US20070196367A1
(en)
|
2006-02-22 |
2007-08-23 |
Valentin Dinu |
Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
|
|
AU2007232206B2
(en)
|
2006-03-30 |
2013-04-04 |
Drais Pharmaceuticals, Inc. |
Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
|
|
EP2148691B1
(en)
|
2007-02-05 |
2015-05-20 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogues for use in the treatment of inflammatory conditions of the respiratory system
|
|
CN106046370A
(zh)
|
2007-02-28 |
2016-10-26 |
塞瑞纳治疗公司 |
聚噁唑啉poz化合物、合成其的方法、以及靶分子‑poz偶联物
|
|
AP2941A
(en)
|
2007-07-19 |
2014-07-31 |
Allexcel Inc |
Self-assembling amphiphilic polymers as anticanceragents
|
|
WO2009015087A2
(en)
|
2007-07-20 |
2009-01-29 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for treatment of trauma
|
|
WO2009043027A2
(en)
|
2007-09-27 |
2009-04-02 |
Serina Therapeutics, Inc. |
Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
|
|
MX2010003630A
(es)
|
2007-10-02 |
2010-04-21 |
Potentia Pharmaceuticals Inc |
Administracion sostenida de analogos de compstatina desde geles.
|
|
CA2705821A1
(en)
|
2007-11-16 |
2009-05-22 |
Novo Nordisk A/S |
Pharmaceutical compositions containing insulin and an insulinotropic peptide
|
|
CN101959934B
(zh)
|
2008-01-11 |
2012-12-12 |
塞瑞纳治疗公司 |
聚噁唑啉共聚物的多官能形式和包含它的药物组合物
|
|
EP2257250A2
(en)
|
2008-01-29 |
2010-12-08 |
Gilbert H. Kliman |
Drug delivery devices, kits and methods therefor
|
|
US20110190221A1
(en)
|
2008-03-28 |
2011-08-04 |
Apellis Ag |
Modulation and repletion/enhancement of the complement system for treatment of trauma
|
|
WO2010006282A2
(en)
|
2008-07-10 |
2010-01-14 |
Serina Therapeutics, Inc. |
Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
|
|
ES2655389T3
(es)
|
2009-05-01 |
2018-02-19 |
The Trustees Of The University Of Pennsylvania |
Compstatina modificada con esqueleto peptídico y modificaciones c-terminales
|
|
US9291622B2
(en)
|
2009-05-21 |
2016-03-22 |
Apellis Pharmaceuticals, Inc. |
Complement assays and uses thereof
|
|
CA2767112C
(en)
|
2009-07-10 |
2018-06-19 |
The General Hospital Corporation |
Etomidate analogues that do not inhibit adrenocortical steroid synthesis
|
|
EP2338520A1
(de)
|
2009-12-21 |
2011-06-29 |
Ludwig Maximilians Universität |
Konjugat mit Zielfindungsligand und dessen Verwendung
|
|
EP2552518A4
(en)
|
2010-04-01 |
2014-08-13 |
Enable Injections Llc |
DEVICE AND SYSTEM FOR INJECTION OF MEDICAL LIQUIDS
|
|
US8625635B2
(en)
|
2010-04-26 |
2014-01-07 |
Cleversafe, Inc. |
Dispersed storage network frame protocol header
|
|
IT1404942B1
(it)
|
2010-06-11 |
2013-12-09 |
Cane Spa |
Dispositivo per l'infusione simultanea di farmaci in piu' siti di infusione.
|
|
WO2011163394A2
(en)
|
2010-06-22 |
2011-12-29 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of neuropathic pain
|
|
US20130324482A1
(en)
|
2010-07-09 |
2013-12-05 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of rhinosinusitis and nasal polyposis
|
|
CA2813049A1
(en)
|
2010-09-23 |
2012-03-29 |
The Trustees Of The University Of Pennsylvania |
Modified compstatin with improved stability and binding properties
|
|
IT1403780B1
(it)
|
2010-12-02 |
2013-10-31 |
Cane Spa |
Dispositivo per l'infusione di farmaci.
|
|
CN107050422B
(zh)
|
2011-05-11 |
2021-11-09 |
阿佩利斯制药公司 |
细胞反应性的、长效的或靶向的坎普他汀类似物及其用途
|
|
CN103796667A
(zh)
|
2011-06-22 |
2014-05-14 |
艾普莱斯制药公司 |
用补体抑制剂治疗慢性障碍的方法
|
|
PL2753636T3
(pl)
|
2011-09-07 |
2020-05-18 |
The Trustees Of The University Of Pennsylvania |
Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych
|
|
US20160067357A1
(en)
|
2012-08-17 |
2016-03-10 |
Apellis Pharmaceuticals, Inc. |
Detection of high risk drusen
|
|
US20150217058A1
(en)
|
2012-09-24 |
2015-08-06 |
Enable Injections, Llc |
Medical vial and injector assemblies and methods of use
|
|
CA2891673C
(en)
*
|
2012-11-15 |
2025-10-07 |
Apellis Pharmaceuticals Inc |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
WO2014078734A2
(en)
*
|
2012-11-15 |
2014-05-22 |
Apellis Pharmaceuticals, Inc. |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
WO2014100407A1
(en)
|
2012-12-19 |
2014-06-26 |
The Regents Of The University Of California |
Compstatin analogs
|
|
ITMI20122263A1
(it)
*
|
2012-12-28 |
2014-06-29 |
Azienda Ospedaliero Universitaria Di Parma |
Nuovi peptidi cationici ciclici ad attività antimicrobica
|
|
CA2901012C
(en)
|
2013-02-15 |
2021-07-06 |
Repro-Med Systems, Inc. |
Multi-flow universal tubing set
|
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
WO2015006915A1
(zh)
|
2013-07-16 |
2015-01-22 |
北京机械设备研究所 |
适用于高层和超高层建筑火灾扑救的消防车
|
|
ITTO20130661A1
(it)
|
2013-08-02 |
2015-02-03 |
Cane Spa |
Pompa portatile per l¿infusione di sostanze liquide nel corpo di un essere vivente e serbatoio per l¿uso in detta pompa
|
|
US9806963B2
(en)
|
2013-10-18 |
2017-10-31 |
Cellco Partnership |
Feature activation on device
|
|
NZ631007A
(en)
*
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
US10213476B2
(en)
|
2014-03-17 |
2019-02-26 |
The Trustees Of The University Of Pennsylvania |
Compstatin analogs with improved potency and pharmacokinetic properties
|
|
US20170246298A1
(en)
*
|
2014-09-24 |
2017-08-31 |
Apellis Pharmaceuticals, Inc. |
Methods and compositions for cancer treatment and treatment selection
|
|
JP6968787B2
(ja)
*
|
2015-10-07 |
2021-11-17 |
アペリス・ファーマシューティカルズ・インコーポレイテッドApellis Pharmaceuticals, Inc. |
投与レジメン
|
|
TWI797073B
(zh)
|
2016-01-25 |
2023-04-01 |
德商安美基研究（慕尼黑）公司 |
包含雙特異性抗體建構物之醫藥組合物
|
|
BR112019007613A2
(pt)
|
2016-10-17 |
2019-07-02 |
Apellis Pharmaceuticals Inc |
terapia de combinação para inibição de c3
|
|
US11040107B2
(en)
|
2017-04-07 |
2021-06-22 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens and related compositions and methods
|
|
KR20240167712A
(ko)
|
2017-12-15 |
2024-11-27 |
아펠리스 파마슈티컬스 인코포레이티드 |
투여 요법 및 관련 조성물 및 방법
|
|
CA3143257A1
(en)
*
|
2019-07-05 |
2021-01-14 |
Apellis Pharmaceuticals, Inc. |
Viral vector therapy
|